Publicaciones en colaboración con investigadores/as de University of Groningen (39)

2026

  1. Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

    The Lancet, Vol. 407, Núm. 10524, pp. 161-173

  2. Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction

    The New England journal of medicine, Vol. 394, Núm. 10, pp. 958-968

  3. Quality of life after decompressive surgery for severe cerebral venous thrombosis

    Journal of Stroke and Cerebrovascular Diseases, Vol. 35, Núm. 3

  4. Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC

    ESMO Open, Vol. 11, Núm. 2

2025

  1. Multicenter study on long-term growth in patients with phenylketonuria

    Orphanet journal of rare diseases, Vol. 20, Núm. 1, pp. 400

  2. Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines

    Journal of Inherited Metabolic Disease, Vol. 48, Núm. 5

  3. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

    Journal of Hepatology, Vol. 83, Núm. 5, pp. 1069-1076

  4. Seizures after decompressive surgery for cerebral venous thrombosis

    Journal of Neurology, Vol. 272, Núm. 10

  5. Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial

    International Journal of Cardiology, Vol. 438

  6. State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres

    Molecular Genetics and Metabolism, Vol. 145, Núm. 3

  7. Timing of starting anticoagulation following decompressive surgery for cerebral vein and sinus thrombosis: An observational study

    International Journal of Stroke, Vol. 20, Núm. 10, pp. 1225-1234

2024

  1. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

  2. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 859-883

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Association of obesity with 3-month mortality in kidney failure patients with COVID-19

    Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1348-1360

  2. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19

    Transplantation, Vol. 106, Núm. 5, pp. 1012-1023

  3. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Clinical journal of the American Society of Nephrology : CJASN

  4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151